Nextera AS
Opening a new arena for drug discovery
Opening a new arena for drug discovery
Nextera AS is a biotechnology startup based in Norway founded in 2009. The company's slogan, "Opening a new arena for drug discovery," reflects its mission to revolutionize therapeutic intervention in autoimmunity, chronic inflammatory disorders, and cancer. Nextera's distinctive approach involves modulating diseases at the core of the escalating immune cascade, thus enabling disease-specific treatments without compromising systemic immunity.
The company's strategy focuses on discovering new targets and developing cognate drugs in collaboration with partners to address complex diseases. Nextera's emphasis on patient-centric solutions entails a deep understanding of diseased tissue and underlying immune repertoires, providing the unique capability to decipher clinical material and intervene accordingly.
Nextera received its Seed Round investment on 01 January 2010 from Birk Venture. With a focus on biotechnology, healthcare, and pharmaceuticals, the company aims to make significant contributions in the field of drug and target discovery.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
01 Jan 2010 |
No recent news or press coverage available for Nextera AS.
We care about your data, and we'd love to use cookies make your experience better.
